US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 74.590
  • -0.860-1.14%
Close Nov 29 13:00 ET
  • 76.000
  • +1.410+1.89%
Post 16:24 ET
14.37BMarket Cap828.78P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Incyte Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.08B
1.14B
+60.71M
Beat Est.
+17.21%
+23.81%
+5.64%
EPS
0.79
0.54
-0.25
Miss Est.
+3.37%
-28.95%
-31.26%
Analyst Rating
Buy

Nov 30, 2024

Incyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.003B--
--2024/Q4-- / 1.145B--
Oct 29, 20242024/Q31.138B / 1.077B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.003B--
--2024/Q4-- / 1.145B--
Oct 29, 20242024/Q31.138B / 1.077B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--

Unlock Free Earnings Estimates

Incyte Earnings Reports

  • Incyte | 10-Q: Q3 2024 Earnings Report

    Oct 29 16:05 ET

  • Incyte | 8-K: Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

    Oct 29 07:08 ET

  • Incyte | 10-Q: Q2 2024 Earnings Report

    Jul 30 16:18 ET

  • Incyte | 8-K: Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

    Jul 30 07:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      44.44%

    • Sell

      5.56%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday+0.39%